O	0	11	Preparation	Preparation	NN	B-NP
O	12	15	and	and	CC	O
O	16	31	physicochemical	physicochemical	JJ	B-NP
O	32	35	and	and	CC	I-NP
O	36	49	immunological	immunological	JJ	I-NP
O	50	66	characterization	characterization	NN	I-NP
O	67	69	of	of	IN	B-PP
O	70	84	polysaccharide	polysaccharide	NN	B-NP
O	84	85	-	-	HYPH	B-NP
B-Cellular_component	85	90	outer	outer	JJ	I-NP
I-Cellular_component	91	99	membrane	membrane	NN	I-NP
O	100	107	protein	protein	NN	I-NP
O	108	117	complexes	complex	NNS	I-NP
O	118	120	of	of	IN	B-PP
O	121	130	Neisseria	Neisseria	NNP	B-NP
O	131	143	meningitidis	meningitidis	NNP	I-NP
O	143	144	.	.	.	O

O	145	146	A	A	DT	B-NP
O	147	152	crude	crude	JJ	I-NP
O	153	160	complex	complex	NN	I-NP
O	161	171	containing	contain	VBG	B-VP
O	172	177	group	group	NN	B-NP
O	178	179	C	C	NN	I-NP
O	180	194	polysaccharide	polysaccharide	NN	I-NP
O	194	195	,	,	,	O
B-Cellular_component	196	201	outer	outer	JJ	B-NP
I-Cellular_component	202	210	membrane	membrane	NN	I-NP
O	211	219	proteins	protein	NNS	I-NP
O	219	220	,	,	,	O
O	221	224	and	and	CC	O
O	225	243	lipopolysaccharide	lipopolysaccharide	NN	B-NP
O	244	245	(	(	(	O
O	245	248	LPS	LPS	NN	B-NP
O	248	249	)	)	)	O
O	250	253	was	be	VBD	B-VP
O	254	262	isolated	isolate	VBN	I-VP
O	263	267	from	from	IN	B-PP
O	268	271	the	the	DT	B-NP
B-Cell	272	276	cell	cell	NN	I-NP
O	276	277	-	-	HYPH	B-NP
O	277	281	free	free	JJ	I-NP
O	282	289	culture	culture	NN	I-NP
O	290	296	liquid	liquid	NN	I-NP
O	297	299	of	of	IN	B-PP
O	300	309	Neisseria	Neisseria	NNP	B-NP
O	310	322	meningitidis	meningitidis	NNP	I-NP
O	323	332	serogroup	serogroup	NN	I-NP
O	333	334	C	C	NN	I-NP
O	334	335	,	,	,	O
O	336	344	serotype	serotype	NN	B-NP
O	345	347	2a	2a	NN	I-NP
O	347	348	.	.	.	O

O	349	354	Group	Group	NN	B-NP
O	355	356	C	C	NN	I-NP
O	357	371	polysaccharide	polysaccharide	NN	I-NP
O	372	375	and	and	CC	O
O	376	379	LPS	LPS	NN	B-NP
O	380	384	were	be	VBD	B-VP
O	385	392	removed	remove	VBN	I-VP
O	393	397	from	from	IN	B-PP
O	398	402	this	this	DT	B-NP
O	403	410	complex	complex	NN	I-NP
O	410	411	,	,	,	O
O	412	421	resulting	result	VBG	B-VP
O	422	424	in	in	IN	B-PP
O	425	427	an	an	DT	B-NP
B-Cellular_component	428	433	outer	outer	JJ	I-NP
I-Cellular_component	434	442	membrane	membrane	NN	I-NP
O	443	450	complex	complex	NN	I-NP
O	451	454	and	and	CC	O
O	455	456	a	a	DT	B-NP
O	457	465	purified	purify	VBN	I-NP
O	466	473	complex	complex	NN	I-NP
O	473	474	,	,	,	O
O	475	487	respectively	respectively	RB	B-ADVP
O	487	488	.	.	.	O

O	489	497	Analysis	Analysis	NN	B-NP
O	498	500	by	by	IN	B-PP
O	501	509	electron	electron	NN	B-NP
O	510	520	microscopy	microscopy	NN	I-NP
O	521	527	showed	show	VBD	B-VP
O	528	531	the	the	DT	B-NP
B-Cellular_component	532	537	outer	outer	JJ	I-NP
I-Cellular_component	538	546	membrane	membrane	NN	I-NP
O	547	553	origin	origin	NN	I-NP
O	554	556	of	of	IN	B-PP
O	557	560	the	the	DT	B-NP
O	561	566	crude	crude	JJ	I-NP
O	567	574	complex	complex	NN	I-NP
O	575	578	and	and	CC	O
O	579	582	the	the	DT	B-NP
B-Cellular_component	583	588	outer	outer	JJ	I-NP
I-Cellular_component	589	597	membrane	membrane	NN	I-NP
O	598	605	complex	complex	NN	I-NP
O	605	606	,	,	,	O
O	607	614	whereas	whereas	IN	O
O	615	619	such	such	PDT	B-NP
O	620	621	a	a	DT	I-NP
O	622	631	structure	structure	NN	I-NP
O	632	635	was	be	VBD	B-VP
O	636	642	absent	absent	JJ	B-ADJP
O	643	645	in	in	IN	B-PP
O	646	649	the	the	DT	B-NP
O	650	658	purified	purify	VBN	I-NP
O	659	666	complex	complex	NN	I-NP
O	666	667	.	.	.	O

O	668	674	Sodium	Sodium	NN	B-NP
O	675	682	dodecyl	dodecyl	NN	I-NP
O	683	690	sulfate	sulfate	NN	I-NP
O	690	691	-	-	HYPH	B-NP
O	691	705	polyacrylamide	polyacrylamide	NN	I-NP
O	706	709	gel	gel	NN	I-NP
O	710	725	electrophoresis	electrophoresis	NN	I-NP
O	726	734	patterns	pattern	NNS	I-NP
O	735	737	of	of	IN	B-PP
O	738	741	the	the	DT	B-NP
O	742	747	three	three	CD	I-NP
O	748	757	complexes	complex	NNS	I-NP
O	758	762	were	be	VBD	B-VP
O	763	772	identical	identical	JJ	B-ADJP
O	772	773	.	.	.	O

O	774	783	Pyrolysis	Pyrolysis	NN	B-NP
O	783	784	-	-	HYPH	I-NP
O	784	788	mass	mass	NN	I-NP
O	789	801	spectrometry	spectrometry	NN	I-NP
O	802	806	data	datum	NNS	I-NP
O	807	817	correlated	correlate	VBD	B-VP
O	818	822	well	well	RB	B-ADVP
O	823	827	with	with	IN	B-PP
O	828	833	those	those	DT	B-NP
O	834	842	obtained	obtain	VBN	B-VP
O	843	845	by	by	IN	B-PP
O	846	849	the	the	DT	B-NP
O	850	861	biochemical	biochemical	JJ	I-NP
O	862	868	assays	assay	NNS	I-NP
O	869	872	and	and	CC	O
O	873	882	suggested	suggest	VBD	B-VP
O	883	884	a	a	DT	B-NP
O	885	888	low	low	JJ	I-NP
O	889	892	LPS	LPS	NN	I-NP
O	893	900	content	content	NN	I-NP
O	901	903	in	in	IN	B-PP
O	904	907	the	the	DT	B-NP
O	908	916	purified	purify	VBN	I-NP
O	917	924	complex	complex	NN	I-NP
O	925	928	and	and	CC	O
O	929	930	a	a	DT	B-NP
O	931	934	low	low	JJ	I-NP
O	935	949	polysaccharide	polysaccharide	NN	I-NP
O	950	957	content	content	NN	I-NP
O	958	960	in	in	IN	B-PP
O	961	964	the	the	DT	B-NP
B-Cellular_component	965	970	outer	outer	JJ	I-NP
I-Cellular_component	971	979	membrane	membrane	NN	I-NP
O	980	987	complex	complex	NN	I-NP
O	987	988	.	.	.	O

O	989	992	The	The	DT	B-NP
O	993	1001	purified	purify	VBN	I-NP
O	1002	1009	complex	complex	NN	I-NP
O	1010	1013	was	be	VBD	B-VP
O	1014	1019	shown	show	VBN	I-VP
O	1020	1022	to	to	TO	I-VP
O	1023	1025	be	be	VB	I-VP
O	1026	1038	nonpyrogenic	nonpyrogenic	JJ	B-ADJP
O	1039	1042	and	and	CC	O
O	1043	1048	could	could	MD	B-VP
O	1049	1051	be	be	VB	I-VP
O	1052	1060	prepared	prepare	VBN	I-VP
O	1061	1065	with	with	IN	B-PP
O	1066	1069	the	the	DT	B-NP
O	1070	1074	same	same	JJ	I-NP
O	1075	1080	yield	yield	NN	I-NP
O	1081	1083	as	as	IN	B-PP
O	1084	1088	that	that	DT	B-NP
O	1089	1091	of	of	IN	B-PP
O	1092	1100	purified	purify	VBN	B-NP
O	1101	1115	polysaccharide	polysaccharide	NN	I-NP
O	1115	1116	.	.	.	O

O	1117	1120	The	The	DT	B-NP
O	1121	1132	immunogenic	immunogenic	JJ	I-NP
O	1133	1143	activities	activity	NNS	I-NP
O	1144	1146	of	of	IN	B-PP
O	1147	1150	the	the	DT	B-NP
O	1151	1160	complexes	complex	NNS	I-NP
O	1161	1165	were	be	VBD	B-VP
O	1166	1173	studied	study	VBN	I-VP
O	1174	1176	in	in	IN	B-PP
O	1177	1181	mice	mouse	NNS	B-NP
O	1181	1182	.	.	.	O

O	1183	1186	The	The	DT	B-NP
O	1187	1197	antibodies	antibody	NNS	I-NP
O	1198	1202	were	be	VBD	B-VP
O	1203	1211	measured	measure	VBN	I-VP
O	1212	1214	by	by	IN	B-PP
O	1215	1218	the	the	DT	B-NP
O	1219	1225	enzyme	enzyme	NN	I-NP
O	1225	1226	-	-	HYPH	B-VP
O	1226	1232	linked	link	VBN	B-NP
O	1233	1246	immunosorbent	immunosorbent	NN	I-NP
O	1247	1252	assay	assay	NN	I-NP
O	1252	1253	;	;	:	O
O	1254	1257	and	and	CC	O
O	1258	1261	the	the	DT	B-NP
O	1262	1274	bactericidal	bactericidal	JJ	I-NP
O	1275	1283	antibody	antibody	NN	I-NP
O	1284	1289	assay	assay	NN	I-NP
O	1289	1290	.	.	.	O

O	1291	1294	All	All	DT	B-NP
O	1295	1304	complexes	complex	NNS	I-NP
O	1305	1312	induced	induce	VBD	B-VP
O	1313	1327	immunoglobulin	immunoglobulin	NN	B-NP
O	1328	1329	G	G	NN	I-NP
O	1330	1340	antibodies	antibody	NNS	I-NP
O	1341	1343	to	to	TO	B-PP
O	1344	1349	group	group	NN	B-NP
O	1350	1351	C	C	NN	I-NP
O	1352	1366	polysaccharide	polysaccharide	NN	I-NP
O	1367	1369	as	as	RB	B-CONJP
O	1370	1374	well	well	RB	I-CONJP
O	1375	1377	as	as	IN	I-CONJP
O	1378	1380	to	to	TO	B-PP
O	1381	1384	the	the	DT	B-NP
O	1385	1393	serotype	serotype	NN	I-NP
O	1394	1401	antigen	antigen	NN	I-NP
O	1401	1402	,	,	,	O
O	1403	1411	although	although	IN	B-SBAR
O	1412	1415	the	the	DT	B-NP
O	1416	1423	removal	removal	NN	I-NP
O	1424	1426	of	of	IN	B-PP
O	1427	1441	polysaccharide	polysaccharide	NN	B-NP
O	1442	1445	and	and	CC	I-NP
O	1446	1449	LPS	LPS	NN	I-NP
O	1450	1458	resulted	result	VBD	B-VP
O	1459	1461	in	in	IN	B-PP
O	1462	1463	a	a	DT	B-NP
O	1464	1473	reduction	reduction	NN	I-NP
O	1474	1476	of	of	IN	B-PP
O	1477	1480	the	the	DT	B-NP
O	1481	1492	immunogenic	immunogenic	JJ	I-NP
O	1493	1503	activities	activity	NNS	I-NP
O	1504	1506	of	of	IN	B-PP
B-Cellular_component	1507	1512	outer	outer	JJ	B-NP
I-Cellular_component	1513	1521	membrane	membrane	NN	I-NP
O	1522	1529	complex	complex	NN	I-NP
O	1530	1533	and	and	CC	O
O	1534	1542	purified	purify	VBN	B-VP
O	1543	1550	complex	complex	NN	B-NP
O	1550	1551	,	,	,	O
O	1552	1564	respectively	respectively	RB	B-ADVP
O	1564	1565	.	.	.	O

O	1566	1567	A	A	DT	B-NP
O	1568	1574	second	second	JJ	I-NP
O	1575	1579	dose	dose	NN	I-NP
O	1580	1582	of	of	IN	B-PP
O	1583	1586	all	all	DT	B-NP
O	1587	1596	complexes	complex	NNS	I-NP
O	1597	1605	produced	produce	VBD	B-VP
O	1606	1607	a	a	DT	B-NP
O	1608	1613	clear	clear	JJ	I-NP
O	1614	1621	booster	booster	NN	I-NP
O	1622	1628	effect	effect	NN	I-NP
O	1629	1631	of	of	IN	B-PP
O	1632	1636	both	both	DT	B-NP
O	1637	1645	antibody	antibody	NN	I-NP
O	1646	1655	responses	response	NNS	I-NP
O	1655	1656	.	.	.	O

O	1657	1660	The	The	DT	B-NP
O	1661	1671	antibodies	antibody	NNS	I-NP
O	1672	1676	were	be	VBD	B-VP
O	1677	1689	bactericidal	bactericidal	JJ	B-ADJP
O	1689	1690	.	.	.	O

